Mawi Heart Company Profile

Background

Overview

Mawi Heart is a digital health company specializing in wearable medical devices and technology for diagnosing and monitoring cardiac diseases. Founded in 2017, the company integrates advanced wearables with smart analytics software to provide comprehensive cardiac monitoring solutions. Mawi Heart operates in Europe, the United States, and the Middle East, collaborating with over 60 hospitals worldwide.

Mission and Vision

Mawi Heart's mission is to revolutionize the diagnosis, response, and prevention of the world's leading causes of death: heart failures, heart attacks, and strokes. The company aims to empower healthcare professionals with a suite of cardiac monitoring tools that span the full risk spectrum of patients, from short-term ambulatory Holter monitoring to long-term remote patient monitoring.

Industry Significance

In the digital health sector, Mawi Heart stands out by combining FDA/CE-cleared wearables with smart analytics software, offering healthcare professionals a comprehensive suite of cardiac monitoring tools. This integration enhances the early detection and management of cardiovascular conditions, addressing a critical need in global healthcare.

Key Strategic Focus

Core Objectives

Mawi Heart focuses on developing innovative cardiac monitoring solutions that are comfortable for patients and efficient for healthcare providers. The company's objectives include:

Designing user-friendly wearable devices for continuous cardiac health monitoring.

Integrating advanced analytics to detect and manage cardiovascular conditions effectively.

Expanding global reach to provide accessible cardiac monitoring solutions.

Areas of Specialization

Mawi Heart specializes in:

Wearable cardiac monitoring devices.

Remote patient monitoring solutions.

AI-driven ECG analytics.

Key Technologies Utilized

The company employs:

Photoplethysmography (PPG) and electrocardiography (ECG) technologies for continuous heart rate and rhythm monitoring.

AI algorithms for beat-to-beat analysis and detection of rhythm abnormalities.

Telehealth platforms for real-time data transmission and analysis.

Primary Markets Targeted

Mawi Heart targets:

Healthcare providers and hospitals.

Patients requiring continuous cardiac monitoring.

Telehealth and remote patient monitoring services.

Financials and Funding

Funding History

Mawi Heart has raised a total of $100,000 over one funding round. The latest funding was an Incubator/Accelerator round of $100,000 on May 15, 2025, with Google for Startups Ukraine Support Fund as the investor.

Utilization of Capital

The capital raised is intended to support the development and expansion of Mawi Heart's cardiac monitoring solutions, enhance research and development efforts, and facilitate market expansion.

Pipeline Development

Key Pipeline Candidates

Mawi Heart's primary product is the Mawi Watch, a medical-grade wearable device designed for continuous cardiac health monitoring. The device is equipped with PPG and ECG technologies to track heart rate, blood oxygen levels, respiratory rate, and heart rate variability. It also monitors blood pressure using pulse wave analysis without the need for cuffs. The Mawi Watch is integrated with remote patient monitoring software that provides healthcare practitioners with real-time health data and high-risk alerts.

Stages of Development

The Mawi Watch has been developed and is currently available for deployment in healthcare settings. The company continues to refine the device and its software to enhance performance and user experience.

Target Conditions

The Mawi Watch is designed to monitor and detect various cardiovascular conditions, including:

Atrial fibrillation (AFib).

Hypertension.

Bradycardia and tachycardia.

Other arrhythmias.

Anticipated Milestones

Mawi Heart aims to achieve the following milestones:

Expand the deployment of Mawi Watch across additional healthcare facilities.

Enhance AI algorithms for improved detection accuracy.

Increase patient adoption and engagement with the monitoring system.

Technological Platform and Innovation

Proprietary Technologies

Mawi Heart's proprietary technologies include:

A single-use, fully disposable wearable patch for cardiac monitoring.

Integrated PPG and ECG sensors for comprehensive heart health tracking.

AI-driven analytics for real-time detection of rhythm abnormalities.

Significant Scientific Methods

The company employs:

Beat-to-beat analysis using AI algorithms to detect critical rhythm abnormalities.

Pulse wave analysis for continuous blood pressure monitoring without cuffs.

Telehealth integration for remote patient monitoring and data transmission.

Leadership Team

Executive Profiles

Ron Fridman: Co-founder and CEO. Ron has extensive experience in the medtech industry, focusing on cardiac monitoring solutions. He leads Mawi Heart's strategic direction and partnerships.

Artem Malynovskyi: Co-founder and CTO. Artem oversees the technological development of Mawi Heart's products, ensuring innovation and quality in the company's offerings.

Vitalii Sahan: Co-founder and VP of Engineering. Vitalii leads the engineering team, driving the development and implementation of Mawi Heart's wearable devices and software solutions.

Andrew Klymenko: Co-founder and President & Chairman of the Board. Andrew plays a key role in guiding Mawi Heart's strategic initiatives and fostering partnerships within the healthcare sector.

Competitor Profile

Market Insights and Dynamics

The digital health sector, particularly in cardiac monitoring, is experiencing significant growth due to the increasing prevalence of cardiovascular diseases and the demand for remote patient monitoring solutions. Advancements in wearable technology and AI analytics are driving innovation and competition in this market.

Competitor Analysis

Mawi Heart faces competition from companies such as:

Peerbridge Health: Specializes in remote cardiac monitoring with wearable devices leveraging AI for heart failure detection.

InfoBionic: Offers a virtual cardiac telemetry platform with analysis and interchangeable biosensor lead sets for various patient acuity levels.

Wellysis: Provides continuous ECG and EKG monitors with AI reporting to assist physicians in diagnosing conditions.

WearLinq: Delivers digital healthcare solutions in cardiac monitoring, including wireless 6-lead cardiac monitors and cardiology report services.

Hexoskin: Focuses on smart clothing and wearable technology for health monitoring, including cardiac, respiratory, and activity metrics.

Seers: Offers integrated solutions for remote patient monitoring, including cardiac monitoring with bio patches and cloud-based analysis software.

Strategic Collaborations and Partnerships

In October 2022, Mawi Heart announced a strategic collaboration with AccurKardia to integrate automated ECG analytics into the Mawi Watch. This partnership aims to enhance the early detection of life-threatening cardiovascular conditions through advanced analytics.

Operational Insights

Mawi Heart differentiates itself by offering a single-use, fully disposable wearable patch that is lightweight, slim, and showerproof, providing a comfortable patient experience. The integration of AI-driven analytics for beat-to-beat analysis and rapid report generation streamlines the workflow for healthcare providers, enabling faster decision-making.

Strategic Opportunities and Future Directions

Mawi Heart is well-positioned to expand its market presence by: